|  Help  |  About  |  Contact Us

Publication : Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells.

First Author  Guillermet-Guibert J Year  2015
Journal  PLoS Genet Volume  11
Issue  7 Pages  e1005304
PubMed ID  26132308 Mgi Jnum  J:228659
Mgi Id  MGI:5708435 Doi  10.1371/journal.pgen.1005304
Citation  Guillermet-Guibert J, et al. (2015) Novel Role for p110beta PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells. PLoS Genet 11(7):e1005304
abstractText  The organismal roles of the ubiquitously expressed class I PI3K isoform p110beta remain largely unknown. Using a new kinase-dead knockin mouse model that mimics constitutive pharmacological inactivation of p110beta, we document that full inactivation of p110beta leads to embryonic lethality in a substantial fraction of mice. Interestingly, the homozygous p110beta kinase-dead mice that survive into adulthood (maximum ~26% on a mixed genetic background) have no apparent phenotypes, other than subfertility in females and complete infertility in males. Systemic inhibition of p110beta results in a highly specific blockade in the maturation of spermatogonia to spermatocytes. p110beta was previously suggested to signal downstream of the c-kit tyrosine kinase receptor in germ cells to regulate their proliferation and survival. We now report that p110beta also plays a germ cell-extrinsic role in the Sertoli cells (SCs) that support the developing sperm, with p110beta inactivation dampening expression of the SC-specific Androgen Receptor (AR) target gene Rhox5, a homeobox gene critical for spermatogenesis. All extragonadal androgen-dependent functions remain unaffected by global p110beta inactivation. In line with a crucial role for p110beta in SCs, selective inactivation of p110beta in these cells results in male infertility. Our study is the first documentation of the involvement of a signalling enzyme, PI3K, in the regulation of AR activity during spermatogenesis. This developmental pathway may become active in prostate cancer where p110beta and AR have previously been reported to functionally interact.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

11 Bio Entities

0 Expression